Bora Pharmaceuticals Co., Ltd. (6472.TW) — Stock Score Summary

Bora Pharmaceuticals Co., Ltd. (6472.TW) has a MoatMap StockRank of 43/100 based on Quality (54/100), Value (52/100), and Momentum (24/100) factor scores. The current signal is HOLD. Bora Pharmaceuticals is Taiwan's premier CDMO, rapidly expanding its global footprint through strategic US acquisitions. It possesses a deep regulatory moat and high-utilization facilities, making it an indispensable partner for global pharma looking to diversify supply chains away from geopolitically sensitive regions.

Bora Pharmaceuticals Co., Ltd. is a contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquid, and semi-solid pharmaceuticals. The company operates world-class, FDA-approved manufacturing facilities, positioning it as a preferred outsourcing partner for global pharma majors. It is Taiwan's largest pharmaceutical CDMO, rapidly expanding its global footprint through strategic international acquisitions.

Key Financial Metrics

Price$12.12
Market Cap$1.4B
P/E (TTM)11.06
P/E (Forward)6.49
Price/Book3.14
Return on Equity11.0%
Return on Invested Capital18.4%
Debt/Equity105.52
Gross Margin40.0%
Operating Margin10.2%
Revenue Growth-10.7%
Dividend Yield3.2%
Free Cash Flow$1M

Bora Pharmaceuticals Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Bora Pharmaceuticals Co., Ltd.’s (6472.TW) StockRank?
MoatMap’s StockRank for Bora Pharmaceuticals Co., Ltd. (6472.TW) is 43/100, with a Hold signal. It is a composite of Quality (54), Value (52), and Momentum (24) factor ranks across MoatMap’s 19,000+ stock universe.
Does Bora Pharmaceuticals Co., Ltd. have an economic moat?
Bora Pharmaceuticals Co., Ltd. (6472.TW) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bora Pharmaceuticals Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Bora Pharmaceuticals Co., Ltd. (6472.TW) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bora Pharmaceuticals Co., Ltd. in?
Bora Pharmaceuticals Co., Ltd. (6472.TW) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Taiwan).
Browse all ranked stocks6472.TW deep dive reportAI ChampionsHow we score stocksSense-check another stock